Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to assess the safety, reactogenicity and immunogenicity of the GSK Biologicals\' pneumococcal vaccine 2830930A in toddlers aged 12 to 23 months at study entry.
Epistemonikos ID: ccab96b4933258e0c737fea3d4fa6f02a790a7d0
First added on: May 10, 2024